LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.

Rusz Orsolya, Papp Orsolya, Vízkeleti Laura, Molnár Béla Ákos, Bende Kristóf Csaba, Lotz Gábor, Ács Balázs, Kahán Zsuzsanna, Székely Tamás, Kulka Janina, Szállási Zoltán, Tőkés Anna-Mária: LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, (82) 1. pp. 139-147. ISSN 0344-5704 (2018)

[img]
Preview
Text
Rusz2018_Article_LAPTM4BGeneCopyNumberGainIsAss1.pdf - Published Version

Download (1MB) | Preview
Item Type: Article
Journal or Publication Title: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Date: 2018
Volume: 82
Number: 1
Page Range: pp. 139-147
ISSN: 0344-5704
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3376691
DOI id: https://doi.org/10.1007/s00280-018-3602-z
Date Deposited: 2019. Feb. 06. 11:59
Last Modified: 2019. Feb. 06. 11:59
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/14636

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year